Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: In comparison with oxidized LDL

Atherosclerosis

Volumn 151, Issue 2, 2000, Pages 481-491

  Hsieh, Chien Cheng ^a   Yen, Mao Hsiung ^a   Liu, Hwan Wun ^a   Lau, Ying Tung ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cytotoxicity; Lysophosphatidylcholine; Oxidized low density lipoprotein; Vascular smooth muscle cell

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANNEXIN; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROGENESIS; CELL CYCLE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL MEMBRANE; CELLS, CULTURED; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MUSCLE, SMOOTH, VASCULAR; PHOSPHATIDYLSERINES; RATS; RATS, INBRED WKY;

EID: 0033867025     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00453-6     Document Type: Article

References (62)

1. Crisby M., Kallin B., Thyberg J., Zhivotovsky B., Orrenius S., Kostulas V., Nilsson J. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis. 130:1997;17-27.
2. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
3. Guyton J.R., Klemp K.F. Transitional features in human atherosclerosis. Intimal thickening, cholesterol clefts and cell loss in human aortic fatty streaks. Am. J. Pathol. 143:1993;1444-1457.
4. Bennett M.R., Boyle J.J. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis. 138:1998;3-9.
5. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury I: smooth muscle growth in the absence of endothelium. Lab. Invest. 49:1983;327-333.
6. Perlmann H., Mailiard L., Krasinski K., Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 95:1997;981-987.
7. Hegyi L., Skepper J.N., Cary N.R.B., Mitchinson M.J. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J. Pathol. 180:1996;423-429.
8. Geng Y.J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme. Am. J. Pathol. 147:1995;251-266.
9. Han D.K.M., Haudenschild C.C., Hong M.K., Tinkle B.T., Leon M.B., Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147:1995;267-277.
10. Falk E. Why do plaques rupture? Circulation. 86(Suppl. III):1992;30-42.
11. Ridolfi R.L., Hutchins G.M. The relationship between coronary artery lesions and myocardial infarcts: ulceration of atherosclerotic plaques precipitating coronary thrombosis. Am. Heart J. 93:1977;468-486.
12. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
13. Hughes H., Mathews B., Lenz M.L., Guyton J.R. Cytotoxicity of oxidized LDL to procine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14:1994;1177-1185.
14. Liu S.X., Zhou M., Chen Y., Wen W.Y., Sun M.J. Lipoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation. Atherosclerosis. 121:1996;55-61.
15. Simon B., Cunningham L.D., Cohen R.A. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J. Clin. Invest. 86:1990;75-79.
16. Galle J., Mulsch A., Busse R., Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler. Thromb. 11:1991;198-203.
17. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B., Esterson M., Fogelman A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
18. Liao F., Berliner J.A., Mehrabian M., Navab M., Demer L.L., Lusis A.J., Fogelman A.M. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87:1991;2253-2257.
19. -). J. Lipid. Res. 35:1994;669-677.
20. Guyton J.R., Lenz M.L., Mathews B., Hughes H., Karsan D., Selinger E., Smith C.V. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis. 118:1995;237-249.
21. Colles S.M., Irwin K.C., Chisolm G.M. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7β-hydroperoxycholesterol. J. Lipid. Res. 37:1996;2018-2028.
22. Cathcart M.K., McNally A.K., Chisolm G.M. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J. Lipid. Res. 32:1991;63-70.
23. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density liporotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 81:1984;3883-3888.
24. Portman O.W., Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J. Lipid. Res. 10:1969;158-165.
25. Keaney J.F. Jr, Xu A., Cunningham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserves endothelial function in cholesterol-fed rabbit by limiting vascular oxidative stress and superoxide generation. J. Clin. Invest. 95:1995;2520-2529.
26. Nilsson J., Dahlgren B., Ares M., Westman J., Nilsson A.H., Cercek B., Shah P.K. Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor. Arterioscler. Thromb. Vasc. Biol. 18:1998;13-19.
27. Nishio E., Arimura S., Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells. A possible role for 7-ketocholesterol. Biochem. Biophys. Res. Commun. 223:1996;413-418.
28. Hsieh C.C., Yen M.H., Lau Y.T. Oxidized low density lipoprotein (oxLDL) and lysophosphatidylcholine (lysoPC) could induce apoptosis of cultured smooth muscle cells (VSMC). Atherosclerosis. 136(Suppl.):1998;S76.
29. Chamley-Campbell J., Campbell G.R., Ross R. The smooth muscle cell in culture. Physiol. Rev. 59:1979;1-61.
30. Hsieh C.C., Lau Y.T. Migration of vascular cells is enhanced in cultures derived from spontaneously hypertensive rat. Pflüg. Arch. Eur. J. Physiol. 435:1998;286-292.
31. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
32. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
33. Murgesan G., Chisolm G.M., Fox P.L. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell. Biol. 120:1993;1011-1019.
34. Schuh J., Fairclough G.F. Jr, Haschemeyer R.H. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 75:1978;3173-3177.
35. Mosmann T. Rapid colormetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
36. Escargueil-Blanc I., Salvayre R., Nègre-Salvayre A. Necrosis and apoptosis induced by oxidized LDL occur through two calcium-dependent pathways in lymphoblastoid cells. FASEB J. 8:1994;1075-1080.
37. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods. 184:1995;39-51.
38. Baumgartner-Parzer S.M., Wanger L., Pettermann M., Grillari J., Gessl A., Waldhäusl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes. 44:1995;1323-1327.
39. 2+-dependent retraction of vascular smooth muscle cells. Circ. Res. 79:1996;871-880.
40. Bjorkerud B., Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler. Thromb. Vasc. Biol. 16:1996;416-424.
41. Sakai M., Miyazaki A., Hakamata H., Sasaki T., Yui S., Yamazaki M., Shichiri M., Houiuchi S. Lysophosphatidylcholine play an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269:1994;31430-31435.
42. Stiko A., Regnstrom J., Shah P.K., Cercek B., Nilsson J. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler. Thromb. Vasc. Biol. 16:1996;194-200.
43. Cathcart M.K., McNally A.K., Chisolm G.M. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J. Lipid. Res. 32:1991;63-70.
44. Mangin E.L., Kugiyama K., Nguy J.H., Kerns S.A., Henry P.K. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ. Res. 72:1993;161-166.
45. Murohara T., Scalia R., Lefer A.M. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ. Res. 78:1996;780-789.
46. Cho S., Hazama M., Urata Y., Goto S., Horiuchi S., Sumikawa K., Kondo T. Protective role of glutathione synthesis in response to oxidized low density lipoprotein in human vascular endothelial cells. Free Radic. Biol. Med. 26:1999;589-602.
47. Stoll L.L., Oskarsson H.J., Spector A.A. Interaction of lysophosphatidylcholine with aortic endothelial cells. Am. J. Physiol. 262:1992;H1853-H1860.
48. Chai Y.C., Howe P.H., DiCorleto P.E., Chisolm G.M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. J. Biol. Chem. 271:1996;17791-17797.
49. Kohno M., Yokokawa K., Yasunari K., Minami M., Kano H., Hanehira T., Yoshikawa J. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation. 98:1998;353-359.
50. Kume N., Cybulsky M.I., Gimbrone M.A. Jr Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1992;1138-1144.
51. Bergamann S.R., Ferguson T.B. Jr, Sobel B.E. Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts. Am. J. Physiol. 240:1981;H229-H237.
52. Ohara Y., Peterson T.E., Zheng B., Kuo J.F., Harrison D.G. Lysophosphatidylcholine increases vascular superoxides anions production via protein kinase C activation. Arterioscler. Thromb. 14:1994;1007-1013.
53. Massaeli H., Pierce G. Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes. Cardiovas. Res. 29:1995;597-603.
54. 2+ channels of the A7r5 smooth muscle-derived cell line. Cell Signal. 5:1997;367-372.
55. 2+ influx in vascular smooth muscle cells. Cell. Physiol. 33:1993;C885-C893.
56. Nishio E., Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 downregulation. Biochem. Biophys. Res. Commun. 226:1996;928-934.
57. Thumser A.E.A., Voysey J.E., Wilton D.C. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem. J. 301:1994;801-806.
58. Jurgen G., Hoff H.F., Chisolm G.M., Esterbauer H. Modification of human serum low density lipoprotein by oxidation - characterization and pathophysiological implications. Chem. Phys. Lipids. 45:1987;315-336.
59. Hessler J.R., Morel D.W., Lewis L.J., Chisolm G.M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:1983;215-222.
60. More D.W., Hessler J.R., Chisolm G.M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid. Res. 24:1983;1070-1076.
61. Hughes H., Mathews B., Lenz M.L., Guyton J.R. Cytotoxicity of oxidized LDL to procine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-ketocholesterol. Arterioscler. Thromb. 14:1994;1177-1185.
62. Colles S.M., Irwin K.C., Chisolm G.M. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7β-hydroperoxycholesterol. J. Lipid Res. 37:1996;2018-2028.